Anila Lingamneni - Jul 11, 2024 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role
EVP, Chief Technology Officer
Signature
/s/ Thomas V. Powers, attorney-in-fact for Ms. Lingamneni
Stock symbol
HAE
Transactions as of
Jul 11, 2024
Transactions value $
-$199,350
Form type
4
Date filed
7/15/2024, 04:27 PM
Previous filing
May 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Sale -$192K -2.14K -9.07% $90.00 21.4K Jul 11, 2024 Direct F1, F2
transaction HAE Common Stock Sale -$7.11K -79 -0.37% $90.00 21.3K Jul 12, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction pursuant to an existing 10b5-1 trading plan dated March 13, 2024 (fully executed as of March 13, 2024).
F2 This number includes unvested restricted stock units previously reported.